ATAD3A
ATPase family AAA domain-containing protein 3A
Also known as: ATD3A_HUMAN, FLJ10709
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NVI7
- Gene
- ATAD3A
- Ensembl
- ENSG00000197785
- Chromosome
- 1
- Canonical length
- 586 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Acrosome
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a ubiquitously expressed mitochondrial membrane protein that contributes to mitochondrial dynamics, nucleoid organization, protein translation, cell growth, and cholesterol metabolism. This gene is a member of the ATPase family AAA-domain containing 3 gene family which, in humans, includes two other paralogs. Naturally occurring mutations in this gene are associated with distinct neurological syndromes including Harel-Yoon syndrome. High-level expression of this gene is associated with poor survival in breast cancer patients. A homozygous knockout of the orthologous gene in mice results in embryonic lethality at day 7.5 due to growth retardation and defective development of the trophoblast lineage. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
Canonical amino-acid sequenceUniProt
586 residues, UniProt reviewed canonical sequence.
>Q9NVI7|ATAD3A
1 MSWLFGINKG PKGEGAGPPP PLPPAQPGAE GGGDRGLGDR PAPKDKWSNF DPTGLERAAK
61 AARELEHSRY AKDALNLAQM QEQTLQLEQQ SKLKEYEAAV EQLKSEQIRA QAEERRKTLS
121 EETRQHQARA QYQDKLARQR YEDQLKQQQL LNEENLRKQE ESVQKQEAMR RATVEREMEL
181 RHKNEMLRVE AEARARAKAE RENADIIREQ IRLKAAEHRQ TVLESIRTAG TLFGEGFRAF
241 VTDWDKVTAT VAGLTLLAVG VYSAKNATLV AGRFIEARLG KPSLVRETSR ITVLEALRHP
301 IQVSRRLLSR PQDALEGVVL SPSLEARVRD IAIATRNTKK NRSLYRNILM YGPPGTGKTL
361 FAKKLALHSG MDYAIMTGGD VAPMGREGVT AMHKLFDWAN TSRRGLLLFV DEADAFLRKR
421 ATEKISEDLR ATLNAFLYRT GQHSNKFMLV LASNQPEQFD WAINDRINEM VHFDLPGQEE
481 RERLVRMYFD KYVLKPATEG KQRLKLAQFD YGRKCSEVAR LTEGMSGREI AQLAVSWQAT
541 AYASEDGVLT EAMMDTRVQD AVQQHQQKMC WLKAEGPGRG DEPSPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATAD3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 32 nTPM
- liver: 28 nTPM
- esophagus: 23 nTPM
- pancreas: 22 nTPM
- heart muscle: 20 nTPM
- pituitary gland: 20 nTPM
Single-cell type
- esophageal basal cells: 62 nCPM
- erythrocyte progenitors: 52 nCPM
- extravillous trophoblasts: 49 nCPM
- migrating cytotrophoblasts: 43 nCPM
- esophageal suprabasal cells: 36 nCPM
- enteric transient amplifying cells: 35 nCPM
Immune cell
- non-classical monocyte: 3.4 nTPM
- NK-cell: 2.5 nTPM
- myeloid DC: 2.2 nTPM
- plasmacytoid DC: 2.2 nTPM
- classical monocyte: 1.8 nTPM
- memory CD8 T-cell: 1.7 nTPM
Brain region
- choroid plexus: 14 nTPM
- hippocampal formation: 12 nTPM
- medulla oblongata: 11 nTPM
- cerebellum: 11 nTPM
- cerebral cortex: 11 nTPM
- basal ganglia: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATAD3A.
Disease | AllUniProt
Conditions ATAD3A is implicated in, by any mechanism.
- Harel-Yoon syndrome (HAYOS) MIM:617183
- Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (PHRINL) MIM:618810
Disease | GeneticClinVar
27 pathogenic / likely-pathogenic of 449 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Harel-Yoon syndrome
- Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal
- ATAD3A-related mitochondrial disorders
- Congenital cerebellar hypoplasia
- ATAD3A deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antiviral innate immune response
- DNA damage response
- HRI-mediated signaling
- mitochondrion organization
- negative regulation of apoptotic process
- negative regulation of PERK-mediated unfolded protein response
- regulation of cell growth
Molecular functions
- ATP binding
- ATP hydrolysis activity
- identical protein binding
- protein serine/threonine kinase inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATAD3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATAD3A as an antibody target. Whether an autoantibody or antibody against ATAD3A could matter depends on whether native ATAD3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATAD3A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATAD3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...